Tortoise Investment Management’s Cardiff Oncology CRDF Stock Holding History

Tortoise Investment Management’s Portfolio CRDF Stock Details CRDF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,000	Closed	-$31.4K	–	1302
2025 Q1	$31.4K	Hold	10,000	–	–	﹤0.01%	438
2024 Q4	$43.4K	Hold	10,000	–	–	﹤0.01%	439
2024 Q3	$26.7K	Hold	10,000	–	–	﹤0.01%	515
2024 Q2	$22.2K	Hold	10,000	–	–	﹤0.01%	515
2024 Q1	$53.4K	Sell	10,000 -5,000	-33%	-$13.3K	0.01%	374
2023 Q4	$22.2K	Hold	15,000	–	–	﹤0.01%	467
2023 Q3	$20.9K	Hold	15,000	–	–	﹤0.01%	462
2023 Q2	$22.1K	Hold	15,000	–	–	﹤0.01%	454
2023 Q1	$24.8K	Hold	15,000	–	–	﹤0.01%	432
2022 Q4	$21K	Hold	15,000	–	–	﹤0.01%	450
2022 Q3	$23K	Hold	15,000	–	–	﹤0.01%	419
2022 Q2	$33K	Hold	15,000	–	–	0.01%	345
2022 Q1	$37K	Hold	15,000	–	–	0.01%	339
2021 Q4	$90K	Hold	15,000	–	–	0.02%	229
2021 Q3	$100K	Sell	15,000 -5,000	-25%	-$31.4K	0.02%	198
2021 Q2	$133K	Sell	20,000 -5,000	-20%	-$42.4K	0.03%	183
2021 Q1	$232K	Hold	25,000	–	–	0.05%	142
2020 Q4	$450K	Hold	25,000	–	–	0.1%	103
2020 Q3	$355K	Hold	25,000	–	–	0.09%	109
2020 Q2	$125K	Buy	+25,000	New	+$51.2K	0.03%	166

Other funds holding CRDF

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tortoise Investment Management's CRDF Position: Q2 2025 in Review

Tortoise Investment Management sold out of Cardiff Oncology (CRDF) in Q2 2025, closing a stake of 10,000 shares — an estimated $31.4K sold.

Tortoise Investment Management first reported a position in CRDF in Q2 2020 and held it in 20 quarters. The position peaked at $450K in Q4 2020. 114 funds tracked by Wall St. Rank hold CRDF as of Q2 2025.

Tortoise Investment Management reported no remaining Cardiff Oncology position as of Q2 2025 after selling out during the quarter.
Tortoise Investment Management sold 10,000 Cardiff Oncology shares in Q2 2025, an estimated $31.4K.
Tortoise Investment Management first reported a position in Cardiff Oncology in Q2 2020 and held it in 20 quarters.
Tortoise Investment Management's Cardiff Oncology position peaked at $450K in Q4 2020.
114 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2025.

Based on Tortoise Investment Management's 13F filing for Q2 2025, filed 8 Aug 2025.